title: Metabolic syndrome in pediatrics.
abstract: The ever growing prevalence of childhood obesity is being accompanied by an increase in the pediatric population of diseases once believed to be exclusive of the adulthood such as the metabolic syndrome (MS). The MS has been defined as the link between insulin resistance, hypertension, dyslipidemia, impaired glucose tolerance, and other metabolic abnormalities associated with an increased risk of atherosclerotic cardiovascular diseases in adults. In this review, we will discuss the peculiar aspects of the pediatric MS and the role of novel molecules and biomarkers in its pathogenesis.
authors.forename: Romy
authors.initials: R
authors.lastname: Kursawe
authors.forename: Nicola
authors.initials: N
authors.lastname: Santoro
mesh_terms: D050154:Adiposity; D000293:Adolescent; D015415:Biomarkers; D002648:Child; D005234:Fatty Liver / Q000209:etiology; D014644:Genetic Variation; D006801:Humans; D024821:Metabolic Syndrome / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism*; D065626:Non-alcoholic Fatty Liver Disease; D011236:Prediabetic State / Q000378:metabolism
chemical_list: D015415:Biomarkers